Knowles Q3 2026 slides: 20% revenue growth driven by precision devices
Knowles Corporation (KN) reported Q3 2026 revenue of $184.0M, up 20.3% YoY, beating estimates. EPS was $0.38, up 15.2% YoY. Precision Devices segment grew 32.7%, while MedTech & Specialty Audio grew 3.6%. Q4 guidance: revenue $180M-$190M, EPS $0.39-$0.43. Shares rose 4.85% after-hours.
How this was made
The 30-second read
Why it matters
The earnings beat and raised guidance provide a fresh catalyst for price movement, especially after the after‑hours rally.
Market read
First‑report earnings with beat and guidance lift; actionable for traders today.
What to watch
Higher capex in 2027 may pressure cash flow if demand slows, and margin compression in the MedTech segment could offset overall gains.
Background
Knowles (NYSE:KN) is a micro‑acoustic and precision‑device maker serving medical, defense, industrial and electrification markets.
Ticker impact
Knowles reported Q3 2026 revenue of $184.0M (+20.3% YoY) beating estimates and raised Q4 guidance, causing a 4.85% after‑hours price jump.
likely upward pressure as investors price in the revenue beat and higher guidance
The company delivered strong top‑line growth, beat consensus, and lifted guidance, all fresh facts that can move the stock immediately.
Market effects
Positive earnings may lift the broader precision‑devices and micro‑acoustic sector, supporting peers in medical‑tech and defense.
U.S. small‑cap market could see modest gains from the beat.
Limited to investors tracking niche acoustic and precision‑device stocks.
Counterpoint
If capacity constraints curb Q1 2027 growth, the current rally could be short‑lived.
Key entities
- ExecutiveJeffrey Niew
CEO who highlighted competitive advantages driving growth.
- ExecutiveJohn Anderson
CFO who discussed capacity expansion and capex plans.


